Literature DB >> 15131267

Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules.

Michael H A Roehrl1, Sunghyun Kang, José Aramburu, Gerhard Wagner, Anjana Rao, Patrick G Hogan.   

Abstract

Transient or reversible protein-protein interactions are commonly used to ensure efficient targeting of signaling enzymes to their cellular substrates. These interactions include direct binding to substrate, interaction with an accessory or scaffold protein, and positioning at subcellular locations in proximity to substrates. The existence of specialized targeting mechanisms raises the possibility of designing inhibitors that do not block enzyme activity per se, but rather interfere with targeting of the enzyme to one or more of its substrates within the cell. Here, we identify small organic molecules that specifically block targeting of the protein phosphatase calcineurin to its substrate nuclear factor of activated T cells (NFAT, also termed NFATc) and show that they are effective inhibitors of calcineurin-NFAT signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131267      PMCID: PMC419644          DOI: 10.1073/pnas.0401835101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

Review 1.  Calcineurin: from structure to function.

Authors:  J Aramburu; A Rao; C B Klee
Journal:  Curr Top Cell Regul       Date:  2000

Review 2.  Small molecule antagonists of proteins.

Authors:  Thomas R Gadek; John B Nicholas
Journal:  Biochem Pharmacol       Date:  2003-01-01       Impact factor: 5.858

Review 3.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

4.  Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy.

Authors:  S A Akhter; L M Luttrell; H A Rockman; G Iaccarino; R J Lefkowitz; W J Koch
Journal:  Science       Date:  1998-04-24       Impact factor: 47.728

5.  A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade.

Authors:  S Tsunoda; J Sierralta; Y Sun; R Bodner; E Suzuki; A Becker; M Socolich; C S Zuker
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

Review 6.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

7.  Inhibition of NFATx activation by an oligopeptide: disrupting the interaction of NFATx with calcineurin.

Authors:  J Liu; K Arai ; N Arai
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

8.  AMPA receptor-PDZ interactions in facilitation of spinal sensory synapses.

Authors:  P Li; G A Kerchner; C Sala; F Wei; J E Huettner; M Sheng; M Zhuo
Journal:  Nat Neurosci       Date:  1999-11       Impact factor: 24.884

9.  A bipartite substrate recognition motif for cyclin-dependent kinases.

Authors:  D Y Takeda; J A Wohlschlegel; A Dutta
Journal:  J Biol Chem       Date:  2000-11-06       Impact factor: 5.157

10.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

Authors:  B A Schulman; D L Lindstrom; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

View more
  67 in total

Review 1.  Designer proteins: applications of genetic code expansion in cell biology.

Authors:  Lloyd Davis; Jason W Chin
Journal:  Nat Rev Mol Cell Biol       Date:  2012-02-15       Impact factor: 94.444

2.  Crystallization and preliminary crystallographic study of a trypsin-resistant catalytic domain of human calcineurin.

Authors:  Lei Jin; Michael H A Roehrl; Li Xiao; Xiuyun He; Haibin Li; Linhu Ge; Bingyi Shi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-04-21

Review 3.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

4.  Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis.

Authors:  Jay Mehta; Anna Genin; Michael Brunner; Lisabeth V Scalzi; Nilamadhab Mishra; Timothy Beukelman; Randy Q Cron
Journal:  Arthritis Rheum       Date:  2010-08

5.  An affinity-based fluorescence polarization assay for protein tyrosine phosphatases.

Authors:  Sheng Zhang; Lan Chen; Sanjai Kumar; Li Wu; David S Lawrence; Zhong-Yin Zhang
Journal:  Methods       Date:  2007-07       Impact factor: 3.608

Review 6.  Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 7.  Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation.

Authors:  Jun O Liu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 8.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

9.  RIAM regulates the cytoskeletal distribution and activation of PLC-gamma1 in T cells.

Authors:  Nikolaos Patsoukis; Esther M Lafuente; Paul Meraner; Jin sub Kim; David Dombkowski; Lequn Li; Vassiliki A Boussiotis
Journal:  Sci Signal       Date:  2009-12-01       Impact factor: 8.192

10.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.

Authors:  Daniela F Quail; Robert L Bowman; Leila Akkari; Marsha L Quick; Alberto J Schuhmacher; Jason T Huse; Eric C Holland; James C Sutton; Johanna A Joyce
Journal:  Science       Date:  2016-05-20       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.